No Detail Found!

Mean Platelet Volume to Lymphocyte Ratio as a Novel Marker for Diabetic Nephropathy.

Author(s)
Mehmet Zahid Kocak Department of Internal Medicine, Abant Izzet Baysal (AIB) University Hospital, Bolu, Turkey
Gulali Aktas Department of Internal Medicine, Abant Izzet Baysal (AIB) University Hospital, Bolu, Turkey
Edip Erkus Department of Internal Medicine, Abant Izzet Baysal (AIB) University Hospital, Bolu, Turkey
Tuba T. Duman Department of Internal Medicine, Abant Izzet Baysal (AIB) University Hospital, Bolu, Turkey
Burcin M. Atak Department of Internal Medicine, Abant Izzet Baysal (AIB) University Hospital, Bolu, Turkey
Haluk Savli Department of Internal Medicine, Abant Izzet Baysal (AIB) University Hospital, Bolu, Turkey
Abstract
Objective: To compare mean platelet volume to lymphocyte ratio (MPVLR) of diabetic nephropathy subjects to those diabetics without diabetic nephropathy. Study Design: Observational, cross-sectional study. Place and Duration of Study: Tertiary referral hospital, in Bolu, Turkey, from July to December 2017. Methodology: Patients with type 2 diabetes mellitus admitted to the Internal Medicine Clinic, were included. Patients were divided into two groups according to the urinary microalbumin/creatinine ratio: diabetic nephropathy and non-nephropathy group. MPVLR was calculated mathematically by division of MPV by lymphocyte count. Results: There were 162 subjects (79 females, 83 males). The MPVLR in patients with diabetic nephropathy and nonnephropathic diabetic groups were 4.1 (2.09-11.84) and 3.4 (1.37-25.56), respectively. The difference was reached statistically significant level (p <0.001). The best cut-off value for MPVLR was 3.66 (AUC=0.733, p <0.001); MPVLR predicted diabetic nephropathy with 71.1% sensitivity and 67.4% specificity, at this level. Conclusion: The MPVLR is an easily calculated and efficient index that can be considered a powerful and independent predictor of diabetic nephropathy in diabetic patients. We suggest that, it can be useful adjunct to standard tests in the diagnosis of diabetic nephropathy.
Publication Details
Page(s) 844-847
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 11, Year: 2018

Request the full text from PASTIC

References
Dalla VestraM,MasieroA,RoiterAM,SallerA,CrepaldiG,FiorettoP, 2003.Is podocyte injury relevant in diabetic nephropathy,Diabetes 52 1031 -5
ChowF,Nikolic-PatersonD,MaF,OzolsE,RollinsB,TeschG, 2007.Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice,Diabetologia 50 471 -80
GoldbergRB, 2009.Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications,J Clin Endocrinol Metab 94 3171 -82
AstrupAS,TarnowL,PietraszekL,SchalkwijkCG,StehouwerCD,Parving H-H, 2008.Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years,Diabetes Care 31 1170 -6
LimAK,TeschGH, 2012.Inflammation in diabetic nephropathy,Mediators Inflamm 146 -54
MartinJ,TrowbridgeE,SalmonG,PlumbJ., 1983.The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration,Thrombosis Res 32 443 -60
SmithRA,BosonnetL,RaratyM,SuttonR,NeoptolemosJP,CampbellF, 2009.Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma,Am J Surg 197 466 -72
KwonHC,KimSH,OhSY,LeeS,LeeJH,ChoiHJ, 2012.Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer,Biomarkers 17 216 -22
TurkmenK,ErdurFM,OzcicekF,OzcicekA,AkbasEM,OzbicerA, .Platelet-to-lymphocyte ratio better predicts, -
TemizA,GaziE,GüngörÖ,BarutçuA,AltunB,BeklerA, 2014.Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction,Med Sci Monitor 20 660 -
AkbasEM,DemirtasL,OzcicekA,TimurogluA,BakirciEM,HamurH, 2014.Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy,Int J Clin Exp Med 7 1794 -
HudzikB,SzkodzinskiJ,LekstonA,GierlotkaM,PolonskiL,GasiorM., 2016.Mean platelet volume-to-lymphocyte ratio: a novel marker of poor short-and long-term prognosis in patients with diabetes mellitus and acute myocardial infarction,J Diabetes Complications 30 1097 -102
KurtulA,AcikgozSK, 2017.Usefulness of mean platelet volume-tolymphocyte ratio for predicting angiographic no-reflow and short-term prognosis after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction,Am J Cardiol 120 534 -41
Le TulzoY,PangaultC,GacouinA,GuillouxV,TributO,AmiotL, 2002.Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome,Shock 18 487 -94
AnX,DingPR,LiYH,WangFH,ShiYX,WangZQ, 2010.Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer,Biomarkers 15 516 -22
OylumluM,YildizA,OylumluM,YükselM,PolatN,BilikMZ, 2015.Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome,Anatol J Cardiol 15 277 -83
KhanYH,SarriffA,AdnanAS,KhanAH,MalhiTH,JummaatF, 2015.Complications associated with end stage renal disease,J Coll Physicians Surg Pak 25 392 -
XueR,GuiD,ZhengL,ZhaiR,WangF,WangN., 2017.Mechanistic insight and management of diabetic nephropathy: Recent progress and future perspective,J Diabetes Res 1839809 -
QamarA,HayatA,AhmadTM,KhanA,HasnatMNU,TahirS., 2018.Serum cystatin C as an early diagnostic biomarker of diabetic kidney disease in type 2 diabetic patients,J Coll Physicians Surg Pak 28 288 -91
MatsusakaT,SandgrenE,ShintaniA,KonV,PastanI,FogoAB, 2011.Podocyte injury damages other podocytes,J Am Soc Nephrol 22 1275 -85
MundelP,ReiserJ, 2010.,Proteinuria: an enzymatic disease of the podocyte? Kidney Int 77 571 -80
CarmenM,NavarroJF, 2006.Inflammation and diabetic nephropathy,Cur Diabetes Rep 6 463 -8
Navarro-GonzálezJF,Mora-FernándezC, 2008.The role of inflammatory cytokines in diabetic nephropathy,J Am Soc Nephrol 19 433 -42
0

Citations

0

Downloads

91

Views